Clinical trial
A Randomized, Placebo-controlled Trial of Prednisone in Refractory Restless Legs Syndrome: a Pilot Study
NCT06631300 is registered in ClinicalTrials.gov with Scripps Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-controlled Trial of Prednisone in Refractory Restless Legs Syndrome: a Pilot Study
- Lead sponsor
- Scripps Health
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- October 1, 2024
- Completion date
- December 31, 2025
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.